The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC)
Phase 2
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Neoplasms, Positron Emission Tomography
Both
Lung Neoplasms, Positron Emission Tomography
Trial Information
The Utility of 18-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) for Radiation Treatment Planning in Non-Small Cell Lung Cancer (NSCLC)
Inclusion Criteria:
- Non-small cell lung cancer to receive radical radiation
Exclusion Criteria:
- unable to tolerate PET/CT scan
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Harold P Lau, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Alberta Health Services
Authority:
Canada: Health Canada
Study ID:
20328
NCT ID:
NCT00385164
Start Date:
October 2006
Completion Date:
Related Keywords:
- Lung Neoplasms
- Positron Emission Tomography
- lung neoplasms
- positron emissions tomography
- radiotherapy planning
- Neoplasms
- Lung Neoplasms
Name | Location |
|---|
